DELCATH SYSTEMS INC. news, videos and press releases
For more news please use our advanced search feature.
DELCATH SYSTEMS INC. - More news...
DELCATH SYSTEMS INC. - More news...
- Encode Ideas, L.P. Announces the Initiation of Research Coverage on Delcath Systems, Inc.
- Delcath Announces Second Quarter 2017 Financial Results
- Delcath Systems To Present At The NobleCon13 - Noble Capital Markets' Thirteenth Annual Investor Conference On January 31, 2017
- New Outcomes Data Using Delcath's Melphalan/HDS To Treat Unresectable Metastatic Ocular Melanoma To The Liver Accepted For Oral Presentation At Regional Cancer Therapies Symposium
- Delcath Announces Ongoing Patient Treatment And Data Collection In Intrahepatic Cholangiocarcinoma Study Cohort
- Delcath Announces Third Quarter Financial Results
- Delcath Issues Letter to Stockholders
- Review Of Delcath's CHEMOSAT Accepted For Publication In Advances In Therapy
- Delcath Announces First European Clinical Sites For FOCUS Phase 3 Trial For Ocular Melanoma Liver Metastases
- Delcath Announces New U.S. Clinical Sites For FOCUS Phase 3 Trial For Ocular Melanoma Liver Metastases
- Delcath To Present At The Dawson James Securities Growth Stock Conference
- Delcath Announces Proposed Public Offering of Common Stock and Warrants
- Delcath Sponsors Ocular Melanoma Foundation Patient Retreat
- Delcath To Present At The 2016 Aegis Growth Conference
- Researchers at leiden univeristy medical center receive outstanding service award for Publication on Delcath's Melphalan/HDS
